A Food-Effect Study of CX11 in Healthy Participants

StatusCompleted
PhasePhase 1
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Study completion date changed from estimate of Sep 30, 2026 to Aug 30, 2026
  2. Enrollment closed, study ongoing
    • Eligibility criteria expanded, about 9 words
    • Site details revised
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 26, 2026 to Mar 4, 2026
    • Site details revised
    v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is to evaluate the food effect (FE) on the PK of 200 mg CX11 in healthy participants
Trial Details
NCT Number NCT07349381
Lead Sponsor Vincentage Pharma Co., Ltd
Collaborators: Corxel Pharmaceuticals
Conditions
(from sponsor)		 Obesity & Overweight, Type 2 Diabetes
Related terms Diabetes Mellitus, Type 2, Obesity, Overweight
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov